Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Østergaard

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Open Forum Infectious Diseases|June 23, 2023
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)Wendy P Bannister, Dorthe Raben, Palle Valentiner-Branth, et al.
Frontiers in Medicine|October 20, 2022
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccinesAstrid K Hvidt, Eva A M Baerends, Ole S Søgaard, et al.
Ebiomedicine|July 14, 2019
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodesMariane H Schleimann, Maria-Louise Kobberø, Line K Vibholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2023
Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort StudyEva A M Baerends, Joanne Reekie, Signe R Andreasen, et al.
Scientific Reports|September 30, 2022
A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumoniaLouise Thorlacius-Ussing, Patrick Terrence Brooks, Henrik Nielsen, et al.
Open Forum Infectious Diseases|January 11, 2023
Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional SurveyMaarten van Wijhe, Kamille Fogh, Steen Ethelberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE StudyOle Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 27, 2024
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2Joanne Reekie, Henrik Stovring, Henrik Nielsen, et al.
Iscience|September 8, 2023
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infectionEva A M Baerends, Astrid K Hvidt, Joanne Reekie, et al.
Communications Medicine|April 24, 2023
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunityLisa Loksø Dietz, Anna Karina Juhl, Ole Schmeltz Søgaard, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Open Forum Infectious Diseases|June 23, 2023
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)Wendy P Bannister, Dorthe Raben, Palle Valentiner-Branth, et al.
Frontiers in Medicine|October 20, 2022
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccinesAstrid K Hvidt, Eva A M Baerends, Ole S Søgaard, et al.
Ebiomedicine|July 14, 2019
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodesMariane H Schleimann, Maria-Louise Kobberø, Line K Vibholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2023
Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort StudyEva A M Baerends, Joanne Reekie, Signe R Andreasen, et al.
Scientific Reports|September 30, 2022
A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumoniaLouise Thorlacius-Ussing, Patrick Terrence Brooks, Henrik Nielsen, et al.
Open Forum Infectious Diseases|January 11, 2023
Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional SurveyMaarten van Wijhe, Kamille Fogh, Steen Ethelberg, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE StudyOle Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 27, 2024
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2Joanne Reekie, Henrik Stovring, Henrik Nielsen, et al.
Iscience|September 8, 2023
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infectionEva A M Baerends, Astrid K Hvidt, Joanne Reekie, et al.
Communications Medicine|April 24, 2023
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunityLisa Loksø Dietz, Anna Karina Juhl, Ole Schmeltz Søgaard, et al.
Pageof 28